US|EN
Select your region & language
Our content and services may vary by location.
US|EN
Back
Smiling employee in a conversation with a colleague in the office
Smiling employee in a conversation with a colleague in the office
ID: 122535

Interim Lead Clinical Research Associate

  • Pharma & Biotech
  • Asap
  • Phase I-III, Oncology, Rare Disease, ICH-GCP
  • K-Recruiting GmbH
Contact:

Julius Strack

+49 89 1890998-614

julius.strack@k-recruiting.com

Overview

Availability
Asap, full-time, onsite & remote
Qualification
Diplom Biology, University (2001)
Language Skills
German (native), English (business fluent)
Relevant Expertise
Clinical Study Manager, Lead CRA, Project Lead, CRO Management, Budget & Timeline Responsibility, Clinical Trials Phase IIII, Monitoring, Authority Submissions (EC, RA), Study Start Up, ICH-GCP, Oncology, Rare Disease, Pharma, BioTech

Key-Facts

  • Over 20 years of experience in Clinical Research, of which 15 years as Study Manager & Lead CRA on national and international level

  • Bright field of experience in different indications e.g. oncology and rare diseases

  • Full responsibility for teams, budgets, timelines, reporting, submissions, protocol monitoring and reviews

  • Profound knowledge with external service providers such as CROs or CMOs

Extract from previous activities

2024 – Dato

CRO Company, Germany

Interim Lead CRA

  • Site Management including monitoring, close out visits, communication to Ethic Committee and Competent Authorities

  • Drive enrolment and data quality of the trial

  • Follow and to maintain scientific and support for the trial

  • Budget responsibility

  • Vendor Management

2023

Biotech Company, Germany

Clinical Study Manager

  • Trial and Site Start-up activities, e.g. recruiting, creating documents, tracker, manuals, protocol, ICF, IB, Risk Management Plan/Communication Plan /TMF Plan, Labels, site documents; budget, contracts (sites, labs, CRO, CMO etc.)

  • Participate in internal and external communications (e.g., meetings, meeting minutes, etc.); work on regulatory and ethics submissions

  • Work on electronic and paper document filing (TMF, Site File, Vendor File)

  • Indication: Oncology, Phase I and II, CAR-T

2021 – 2022

BioTech Company, Germany

Clinical Project Manager

  • Vendor management

  • Planning, implementation and monitoring of all operational processes

  • Coordinate and adhere to budget framework and timelines, selection and payment processing of required vendors

  • Reporting internally and externally; oversight on study start-up activities

  • Indication: Oncology, Phase III, Antibody Drug Conjugate

2020

Pharmaceutical Company, Germany

Trial Capabilities Support

  • Budget and contracts preparation and negotiation with trial sites for interventional studies

  • BfS submissions

2020 – 2021

Pharmaceutical Company, Germany

Study Manager (NIS)

  • Feasibility; Submission to BfArM and Ethics committees of 200 sites in Germany

  • Communication with Sponsor; regular status calls and emails; contract preparation and review

  • CRA training and oversight; Site initiation

  • Indications: Cardiology, Metabolism

2011 – 2017

Pharmaceutical Company, Germany

Clinical Study Manager

  • Project management of interventional (Phase II and III) and non- interventional studies

  • Tracing and conduction of feasibility, site initiation, routine on site monitoring including SDV, close out visits

  • Review of site visit reports

  • Budget tracking, controlling, contract management, CRO management, coordination of all involved departments (Medical Writing, Medical Experts, Data Management, Statistics), submission to ethics committee and regulatory authorities

  • eCRF set up

  • Tracking of invoices and payments to sites; CRA and freelancer management and training, FTE calculation

  • In this position project management and site monitoring were combined

  • Indications: Neurology, Metabolism (short stature, orphan drug), Oncology, Endocrinology, Urology